Institutional investors purchased a net $2.7 million shares of AEGR during the quarter ended September 2015, and now own 122.93% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BROADFIN CAPITAL LLC Bought 1.7 Million shares of Aegerion Pharmaceuticals ...